Analysis of Muscle Mass by Computed Tomography in Patients with Head and Neck Cancer: a Prospective Study

Overview

Journal Radiol Bras

Specialty Radiology

Date 2024 Jan 11

PMID 38204897

Authors

Thais Manfrinato Miola

Almir Galvao Vieira Bitencourt

Juliana de Oliveira Souza

Luiz Paulo Kowalski

Joao Goncalves Filho

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the preoperative muscle mass of patients with head and neck cancer (HNC) with computed tomography (CT), comparing the results obtained through analysis of cross-sectional areas at the level of the third lumbar vertebra (L3) with those obtained through analysis of cross-sectional areas at the levels of the third cervical and fourth thoracic vertebrae (C3 and T4, respectively).

Materials And Methods: A total of 63 patients with HNC were evaluated preoperatively. Using CT, we assessed muscle mass at L3, as well as at C3 and T4.

Results: Most (73.0%) of the patients had low muscle mass at L3, whereas 50.8% had a normal body mass index. The cross-sectional area at L3 correlated strongly with those at C3 and T4 (r = 0.831 and r = 0.763, respectively; < 0.001 for both). In addition, the muscle mass index at L3 correlated strongly with those at C3 and T4 (r = 0.781 and r = 0.715, respectively; < 0.001 for both).

Conclusion: Low muscle mass appears to be highly prevalent in patients with HNC. Measurements at C3 and T4 could represent alternative means of assessing muscle mass in such patients.

References

Nishikawa D, Hanai N, Suzuki H, Koide Y, Beppu S, Hasegawa Y . The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma. ORL J Otorhinolaryngol Relat Spec. 2018; 80(1):1-9. DOI: 10.1159/000485515. View

. [The 30th Meeting of the Advisory Committee on Health Research]. Bol Oficina Sanit Panam. 1995; 119(6):538-46. View

Ackerman D, Laszlo M, Provisor A, Yu A . Nutrition Management for the Head and Neck Cancer Patient. Cancer Treat Res. 2018; 174:187-208. DOI: 10.1007/978-3-319-65421-8_11. View

Ravasco P . Nutrition in Cancer Patients. J Clin Med. 2019; 8(8). PMC: 6723589. DOI: 10.3390/jcm8081211. View

Prado C, Heymsfield S . Lean tissue imaging: a new era for nutritional assessment and intervention. JPEN J Parenter Enteral Nutr. 2014; 38(8):940-53. PMC: 4361695. DOI: 10.1177/0148607114550189. View

Anjanappa M, Corden M, Green A, Roberts D, Hoskin P, McWilliam A . Sarcopenia in cancer: Risking more than muscle loss. Tech Innov Patient Support Radiat Oncol. 2021; 16:50-57. PMC: 7769854. DOI: 10.1016/j.tipsro.2020.10.001. View

Swartz J, Pothen A, Wegner I, Smid E, Swart K, de Bree R . Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients. Oral Oncol. 2016; 62:28-33. DOI: 10.1016/j.oraloncology.2016.09.006. View

Muscaritoli M, Arends J, Aapro M . From guidelines to clinical practice: a roadmap for oncologists for nutrition therapy for cancer patients. Ther Adv Med Oncol. 2019; 11:1758835919880084. PMC: 6854759. DOI: 10.1177/1758835919880084. View

Yoon J, Jang J, An Y, Lee S . Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer. PLoS One. 2021; 16(7):e0254844. PMC: 8289025. DOI: 10.1371/journal.pone.0254844. View

10.

Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F . ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2016; 36(1):11-48. DOI: 10.1016/j.clnu.2016.07.015. View

11.

Ferrao B, Neves P, Santos T, Capelas M, Makitie A, Ravasco P . Body composition changes in patients with head and neck cancer under active treatment: a scoping review. Support Care Cancer. 2020; 28(10):4613-4625. DOI: 10.1007/s00520-020-05487-w. View

12.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

13.

Alhambra Exposito M, Herrera-Martinez A, Manzano Garcia G, Espinosa Calvo M, Bueno Serrano C, Galvez Moreno M . Early nutrition support therapy in patients with head-neck cancer. Nutr Hosp. 2018; 35(3):505-510. DOI: 10.20960/nh.1560. View

14.

Ufuk F, Herek D, Yuksel D . Diagnosis of Sarcopenia in Head and Neck Computed Tomography: Cervical Muscle Mass as a Strong Indicator of Sarcopenia. Clin Exp Otorhinolaryngol. 2019; 12(3):317-324. PMC: 6635710. DOI: 10.21053/ceo.2018.01613. View

15.

Prado C, Ford K, Gonzalez M, Murnane L, Gillis C, Wischmeyer P . Nascent to novel methods to evaluate malnutrition and frailty in the surgical patient. JPEN J Parenter Enteral Nutr. 2022; 47 Suppl 1:S54-S68. PMC: 9905223. DOI: 10.1002/jpen.2420. View

16.

Wysham N, Nipp R, LeBlanc T, Wolf S, Ekstrom M, Currow D . A practical measurement of thoracic sarcopenia: correlation with clinical parameters and outcomes in advanced lung cancer. ERJ Open Res. 2016; 2(2). PMC: 5005176. DOI: 10.1183/23120541.00085-2015. View

17.

Yip C, Dinkel C, Mahajan A, Siddique M, Cook G, Goh V . Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome. Insights Imaging. 2015; 6(4):489-97. PMC: 4519815. DOI: 10.1007/s13244-015-0414-0. View

18.

Mueller C, Compher C, Ellen D . A.S.P.E.N. clinical guidelines: Nutrition screening, assessment, and intervention in adults. JPEN J Parenter Enteral Nutr. 2011; 35(1):16-24. DOI: 10.1177/0148607110389335. View

19.

Gronberg B, Sjoblom B, Wentzel-Larsen T, Baracos V, Hjermstad M, Aass N . A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer. Eur J Clin Nutr. 2018; 73(7):1069-1076. DOI: 10.1038/s41430-018-0325-5. View

20.

Huhmann M, August D . Review of American Society for Parenteral and Enteral Nutrition (ASPEN) Clinical Guidelines for Nutrition Support in Cancer Patients: nutrition screening and assessment. Nutr Clin Pract. 2008; 23(2):182-8. DOI: 10.1177/0884533608314530. View